Research ExplorerJournalsONCOTARGET

ONCOTARGET

Bibliographical data

ISSNs1949-2553
Electronic ISSN 1949-2553

Publications

Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power
Karstens, K-F., Bellon, E., Polonski, A., Wolters-Eisfeld, G., Melling, N., Reeh, M., Izbicki, J. R. & Tachezy, M., 31.03.2020, In: ONCOTARGET. 11, 13, p. 1131-1140 10 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma
Jacobsen, F., Kohsar, J., Gebauer, F., Kluth, M., Hube-Magg, C., Simon, R., Bockhorn, M., Hinsch, A., Burandt, E., Lübke, A. M., Steurer, S., Tachezy, M., Sauter, G., Izbicki, J. R., Wilczak, W. & Melling, N., 24.03.2020, In: ONCOTARGET. 11, 12, p. 1007-1016 10 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes
Büscheck, F., Fraune, C., Simon, R., Kluth, M., Hube-Magg, C., Möller-Koop, C., Sarper, I., Ketterer, K., Henke, T., Eichelberg, C., Dahlem, R., Wilczak, W., Sauter, G., Fisch, M., Eichenauer, T. & Rink, M., 21.01.2020, In: ONCOTARGET. 11, 3, p. 237-249 13 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC
Roeper, J., Falk, M., Chalaris-Rißmann, A., Lueers, A. C., Ramdani, H., Wedeken, K., Stropiep, U., Diehl, L., Tiemann, M., Heukamp, L. C., Otto-Sobotka, F. & Griesinger, F., 21.01.2020, In: ONCOTARGET. 11, 3, p. 250-264 15 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
Steurer, S., Schwemmer, L., Hube-Magg, C., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., Luebke, A. M., Simon, R., Sauter, G., Izbicki, J., Schroeder, C., Schlomm, T., Huland, H., Heinzer, H., Haese, A., Graefen, M., Göbel, C., Weidemann, S., Lebok, P., Dum, D., Fraune, C., Minner, S. & Meiners, J., 24.12.2019, In: ONCOTARGET. 10, 67, p. 7096-7111 16 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma
Dührsen, L., Hartfuß, S., Hirsch, D., Geiger, S., Maire, C. L., Sedlacik, J., Guenther, C., Westphal, M., Lamszus, K., Hermann, F. G. & Schmidt, N. O., 22.10.2019, In: ONCOTARGET. 10, 58, p. 6049-6061 13 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
Bonk, S., Kluth, M., Hube-Magg, C., Polonski, A., Soekeland, G., Makropidi-Fraune, G., Möller-Koop, C., Witt, M., Luebke, A. M., Hinsch, A., Burandt, E., Steurer, S., Clauditz, T. S., Schlomm, T., Perez, D., Graefen, M., Heinzer, H., Huland, H., Izbicki, J. R., Wilczak, W., Minner, S., Sauter, G. & Simon, R., 10.09.2019, In: ONCOTARGET. 10, 52, p. 5439-5453 15 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., Simon, R., Büscheck, F., Luebke, A. M., Goebel, C., Lang, D. S., Weidemann, S., Neubauer, E., Hinsch, A., Jacobsen, F., Lebok, P., Michl, U., Pehrke, D., Huland, H., Graefen, M., Schlomm, T., Sauter, G. & Höflmayer, D., 13.08.2019, In: ONCOTARGET. 10, 48, p. 4973-4986 14 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Reidel, V., Kauschinger, J., Hauch, R. T., Müller-Thomas, C., Nadarajah, N., Burgkart, R., Schmidt, B., Hempel, D., Jacob, A., Slotta-Huspenina, J., Höckendorf, U., Peschel, C., Kern, W., Haferlach, T., Götze, K. S., Jilg, S. & Jost, P. J., 03.04.2019, In: ONCOTARGET. 9, 25, p. 17270-17281 12 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
Eichenauer, T., Hussein, M., Hube-Magg, C., Kluth, M., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Steurer, S., Clauditz, T. S., Luebke, A. M., Burandt, E., Wilczak, W., Hinsch, A., Dum, D., Beyer, B., Steuber, T., Huland, H., Graefen, M., Simon, R., Sauter, G., Melling, N., Schlomm, T. & Minner, S., 01.03.2019, In: ONCOTARGET. 10, 18, p. 1729-1744 16 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (125)